Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-799X (Electronic) Linking ISSN: 1749799X NLM ISO Abbreviation: J Orthop Surg Res Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, 2006-
    • Subject Terms:
    • Abstract:
      Background: Several studies have been conducted to report diagnostic values of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in the many diseases, such as oncological, inflammatory, and some infectious diseases. However, the predictive value of these laboratory parameters for early periprosthetic joint infections (PJIs) has not yet been reported. The aim of this study was to determine predictive values of the postoperative NLR, PLR, and LMR for the diagnosis of PJIs.
      Methods: In this retrospective study, 104 patients (26 early PJI cases and 78 non-PJI cases) who underwent total joint arthroplasty were enrolled in this study. All the patients were then categorized into two groups: PJI group, patients with the diagnosis of PJI (26 patients; 14 males, 12 females; mean age = 65.47 ± 10.23 age range = 51-81 ) and non-PJI group, patients without PJI (78 patients; 40 males, 38 females; mean age = 62.15 ± 9.33, age range = 41-92). We defined "suspected time" as the time that any abnormal symptoms or signs occurred, including fever, local swelling, or redness around the surgical site between 2 and 4 weeks after surgery and before the diagnosis. Suspected time and laboratory parameters, including NLR, PLR, LMR, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), were compared between both groups. The trends of postoperative NLR, LMR, PLR, CRP, and ESR were also reviewed. The predictive ability of these parameters at the suspected time for early PJI was evaluated by multivariate analysis and receiver operating characteristic (ROC) curve analysis.
      Results: NLR, PLR, and LMR returned to preoperative levels within 2 weeks after surgery in the two groups. In the PJI group, NLR and PLR were significantly increased during the incubation period of infection or infection, and LMR was significantly reduced, although 61.5% (16/26) of the patients had normal white blood cells. Interestingly, ESR and CRP were still relatively high 2 weeks after surgery and were not different between the two groups before infection started (p = 0.12 and 0.4, respectively). NLR and PLR were significantly correlated with early PJI (Odds ratios for NLR and PLR = 88.36 and 1.12, respectively; p values for NLR and PLR = 0.005 and 0.01, respectively). NLR had great predictive ability for the diagnosis of early PJI, with a cut-off value of 2.77 (sensitivity = 84.6%, specificity = 89.7%, 95% CI = 0.86-0.97).
      Conclusions: ESR and CRP seem not to be sensitive for the diagnosis of early PJI due to their persistently high levels after arthroplasty. The postoperative NLR at the suspected time may have a great ability to predict early PJI.
    • References:
      J Bone Joint Surg Am. 2006 Dec;88 Suppl 4:138-47. (PMID: 17142443)
      J Arthroplasty. 2014 Jul;29(7):1331. (PMID: 24768547)
      Arch Orthop Trauma Surg. 2017 Aug;137(8):1115-1119. (PMID: 28488017)
      Med Care. 2015 Sep;53(9):e65-72. (PMID: 23703645)
      J Arthroplasty. 2017 Apr;32(4):1387-1394. (PMID: 27817992)
      J Bone Joint Surg Am. 2003;85-A Suppl 1:S75-80. (PMID: 12540674)
      Ulus Travma Acil Cerrahi Derg. 2014 Jan;20(1):19-22. (PMID: 24639310)
      Spine (Phila Pa 1976). 2019 Dec 1;44(23):E1356-E1361. (PMID: 31725684)
      J Bone Joint Surg Br. 2007 Jan;89(1):94-9. (PMID: 17259424)
      Clin Orthop Relat Res. 2011 Nov;469(11):2992-4. (PMID: 21938532)
      J Bone Joint Surg Am. 2017 Dec 6;99(23):2011-2018. (PMID: 29206791)
      J Natl Cancer Inst. 2014 May 29;106(6):dju124. (PMID: 24875653)
      N Engl J Med. 2004 Oct 14;351(16):1645-54. (PMID: 15483283)
      J Bone Joint Surg Am. 2017 Sep 6;99(17):1419-1427. (PMID: 28872523)
      J Arthroplasty. 2019 Oct;34(10):2454-2460. (PMID: 31155460)
      World J Surg Oncol. 2016 Apr 29;14:127. (PMID: 27125872)
      J Vasc Surg. 2017 Feb;65(2):478-483. (PMID: 27887858)
      Surg Infect (Larchmt). 2017 Aug/Sep;18(6):702-710. (PMID: 28686144)
      J Surg Res. 2016 May 15;202(2):284-90. (PMID: 27229102)
      J Arthroplasty. 2016 Sep;31(9):1990-6. (PMID: 27017206)
      Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3287-3292. (PMID: 26704797)
      PLoS One. 2014 Feb 21;9(2):e89045. (PMID: 24586496)
    • Grant Information:
      2020YFC2002800 The Ministry of Science and Technology of China; 201940170 Shanghai Municipal Health Commission Special project of clinical research in health industry (CN)
    • Contributed Indexing:
      Keywords: LMR; NLR; PLR; Periprosthetic joint infection; Total joint arthroplasty
    • Accession Number:
      0 (Biomarkers)
      9007-41-4 (C-Reactive Protein)
    • Publication Date:
      Date Created: 20201201 Date Completed: 20210618 Latest Revision: 20210618
    • Publication Date:
      20240829
    • Accession Number:
      PMC7708199
    • Accession Number:
      10.1186/s13018-020-02107-5
    • Accession Number:
      33256763